| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | EPO (European Patent Office) | 6 | |
| #3 | Canada | 3 | |
| #4 | Australia | 2 | |
| #5 | Hong Kong | 2 | |
| #6 | WIPO (World Intellectual Property Organization) | 2 | |
| #7 | Hungary | 1 | |
| #8 | Italy | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Measuring microorganism processes | |
| #2 | Peptides | |
| #3 | Analysing materials | |
| #4 | Therapeutic chemical compounds | |
| #5 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Falini Brunangelo | 25 |
| #2 | Mecucci Cristina | 14 |
| #3 | Martelli Maria | 4 |
| #4 | Tiacci Enrico | 4 |
| #5 | Rabadan Raul | 4 |
| #6 | Martelli Maria Paola | 2 |
| #7 | Mecucci Christina | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2016324920A1 | Dactinomycin compositions and methods for the treatment of acute myeloid leukemia | |
| AU2012253525A1 | Hairy cell leukemia biomarkers and methods of using same | |
| EP3284750A1 | Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof |